awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34373466-493C6B68-B0BB-465B-8ED0-3A94CAA0209C
Q34373466-493C6B68-B0BB-465B-8ED0-3A94CAA0209C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34373466-493C6B68-B0BB-465B-8ED0-3A94CAA0209C
Interdiction of sphingolipid metabolism to improve standard cancer therapies.
P2860
Q34373466-493C6B68-B0BB-465B-8ED0-3A94CAA0209C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34373466-493C6B68-B0BB-465B-8ED0-3A94CAA0209C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afb2c34fce54e731ceff9f02673c86c617df7d59
P2860
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.